Eslikarbazepin

Warning

This publication doesn't include Institute of Computer Science. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Title in English	Eslicarbazepine
Authors	BRÁZDIL Milan
Year of publication	2011
Type	Article in Periodical
Magazine / Source	Remedia
MU Faculty or unit	Central European Institute of Technology
Citation
Field	Neurology, neurosurgery, neurosciences
Keywords	eslicarbazepine; epilepsy; add-on therapy
Description	Eslicarbazepine acetate (ESL)) is a novel antiepileptic drug that stabilizes the voltage-gated sodium channel. The recommended maintenance dosage after titration is 800-1200 mg given in a single daily dose.
Related projects:	The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.